Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, Lasa Supergenerics has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday August 14 2021 to consider, approve and take on record un-audited financial results along with Limited review report for the quarter ended June 30 2021 and/or to discuss any other business/matter with the permission of the Chair. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till August 16, 2021.
The above information is a part of company’s filings submitted to BSE.